They can't be serious.

This company can't seriously think they are informing the market by sticking a few posters on their website.

New, important research.

Anisina showing fantastic synergistic results with invivo testing using a different cancer type and in combination with a different drug to what has been previously released.

Trilexium showing improved results when used in combination with another drug that when either is used alone invivo with melanoma.

Trilexium showing superior IC50 invitro results to the standard of care chemotherapy for GBM.

This is not a rehash of previous results. Get serious and inform the market accordingly - on the ASX.